GPR6
G-protein coupled receptor 6
Also known as: GPR6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46095
- Gene
- GPR6
- Ensembl
- ENSG00000146360
- Chromosome
- 6
- Canonical length
- 362 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable sphingosine-1-phosphate receptor activity. Predicted to be involved in adenylate cyclase-activating G protein-coupled receptor signaling pathway and regulation of metabolic process. Predicted to act upstream of or within positive regulation of cytosolic calcium ion concentration. Predicted to be located in membrane. Predicted to be active in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
362 residues, UniProt reviewed canonical sequence.
>P46095|GPR6
1 MNASAASLND SQVVVVAAEG AAAAATAAGG PDTGEWGPPA AAALGAGGGA NGSLELSSQL
61 SAGPPGLLLP AVNPWDVLLC VSGTVIAGEN ALVVALIAST PALRTPMFVL VGSLATADLL
121 AGCGLILHFV FQYLVPSETV SLLTVGFLVA SFAASVSSLL AITVDRYLSL YNALTYYSRR
181 TLLGVHLLLA ATWTVSLGLG LLPVLGWNCL AERAACSVVR PLARSHVALL SAAFFMVFGI
241 MLHLYVRICQ VVWRHAHQIA LQQHCLAPPH LAATRKGVGT LAVVLGTFGA SWLPFAIYCV
301 VGSHEDPAVY TYATLLPATY NSMINPIIYA FRNQEIQRAL WLLLCGCFQS KVPFRSRSPS
361 EVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 34 nTPM
- pituitary gland: 3.7 nTPM
- hypothalamus: 3.2 nTPM
- cerebral cortex: 2.3 nTPM
- amygdala: 0.8 nTPM
- hippocampal formation: 0.6 nTPM
Single-cell type
- brain inhibitory neurons: 13 nCPM
- other brain neurons: 4.4 nCPM
- lactotrophs: 4.2 nCPM
- pancreatic islet cells: 1 nCPM
- neuroendocrine cells: 0.9 nCPM
- brain excitatory neurons: 0.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 55 nTPM
- hypothalamus: 15 nTPM
- cerebral cortex: 8.1 nTPM
- thalamus: 4.4 nTPM
- amygdala: 4.2 nTPM
- hippocampal formation: 1.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- G protein-coupled receptor signaling pathway
- positive regulation of cytosolic calcium ion concentration
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPR6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR6 as an antibody target. Whether an autoantibody or antibody against GPR6 could matter depends on whether native GPR6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR6 is annotated at the cell surface, where native GPR6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...